Neptune Wellness Solutions Inc. (NEPTF)
OTCMKTS · Delayed Price · Currency is USD
0.0140
0.00 (0.00%)
Aug 6, 2025, 8:00 PM EDT
Verve Therapeutics Revenue
Neptune Wellness Solutions had revenue of $7.60M in the quarter ending December 31, 2023, a decrease of -37.75%. This brings the company's revenue in the last twelve months to $39.11M, down -24.78% year-over-year. In the fiscal year ending March 31, 2023, Neptune Wellness Solutions had annual revenue of $52.62M with 7.82% growth.
Revenue (ttm)
39.11M
Revenue Growth
-24.78%
P/S Ratio
n/a
Revenue / Employee
782.30K
Employees
50
Market Cap
5.00
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2023 | 52.62M | 3.82M | 7.82% |
Mar 31, 2022 | 48.80M | 13.40M | 37.84% |
Mar 31, 2021 | 35.40M | 14.53M | 69.65% |
Mar 31, 2020 | 20.87M | 2.58M | 14.11% |
Mar 31, 2019 | 18.29M | -3.15M | -14.70% |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Feb 29, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Feb 28, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Feb 28, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
Global Cord Blood | 196.10M |